oneplacenewsSource: ScienceDaily Health
Summary
Researchers found that individuals using GLP-1 weight loss medications, including Ozempic and Wegovy, experienced a decrease in physical activity despite losing weight. The drop in daily steps and exercise levels raises concerns about muscle mass reduction and long-term health implications.
Why It Matters
This decline in physical activity among those on GLP-1 drugs is significant because it may counteract the benefits of weight loss, potentially compromising overall health. Understanding the impact of these medications on lifestyle is crucial for healthcare providers and patients alike, emphasizing the need for balanced approaches to weight management that include physical activity.
